Find answers to common questions about DYANAVEL XR (amphetamine)
DYANAVEL XR is the first once-daily, extended-release liquid amphetamine for the treatment of ADHD. It is a central nervous system stimulant prescription liquid medicine that is taken by mouth once every day in the morning, with or without food. DYANAVEL XR may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD. It is not known if DYANAVEL XR is safe and effective in children under 6 years of age.
DYANAVEL XR may be used as part of a treatment program for ADHD that may include behavioral therapy or other interventions.
The XR stands for “eXtended Release.”
DYANAVEL XR uses technology to allow for a continuous release of amphetamine throughout the day. This means that DYANAVEL XR only needs to be taken once each day in the morning, and the medicine is released throughout the day.
In a clinical study performed in a laboratory classroom, DYANAVEL XR was found to reduce the symptoms of ADHD in children ages 6-12 years at all measured times (1, 2, 4, 6, 8, 10, 12, and 13 hours after taking) compared to a sugar syrup.
The effectiveness of DYANAVEL XR was assessed in a laboratory classroom study. Teachers and raters used a rating scale (SKAMP) to evaluate the efficacy of DYANAVEL XR on attention and behavior in children with ADHD ages 6-12 years. In a clinical study performed in a laboratory classroom, DYANAVEL XR was demonstrated to start working within as little as 1 hour, keep working for 13 hours after taking, and reduce the symptoms of ADHD in children ages 6-12 years at all measured times (1, 2, 4, 6, 8, 10, 12, and 13 hours after taking) compared to a sugar syrup. In the study, most adverse events were classified as mild to moderate in severity and were: Decreased appetite, Insomnia, Affect lability, Upper abdominal pain, Mood swings, Headache.
DYANAVEL XR is bubblegum-flavored.
Store DYANAVEL XR in a safe place at 68°F to 77°F (20°C to 25°C). Keep DYANAVEL XR and all medicines out of the reach of children.
DYANAVEL XR comes as a light beige to tan viscous liquid. You will be given 1 bottle (containing the liquid form of DYANAVEL XR), 1 oral dosing dispenser, and 1 bottle adapter that will have already been inserted into the bottle by the pharmacist. Please refer to the Instructions for Use for a full description of each item.
Take DYANAVEL XR exactly as prescribed. Your healthcare provider may adjust the dose until it is right for you or your child
DYANAVEL XR should be used with the oral dosing dispenser provided with the product. If the oral dosing dispenser is missing or not provided, please contact your pharmacist
DYANAVEL XR can be taken with or without food
Children should have their height and weight checked often while taking DYANAVEL XR. DYANAVEL XR treatment may be stopped if a problem is found during these check-ups
In case of poisoning, call your poison control center at 1-800-222-1222 right away, or go to the nearest hospital emergency room
DYANAVEL XR was demonstrated to start working at 1 hour after taking. In a clinical study performed in a laboratory classroom, DYANAVEL XR was found effective at reducing the symptoms of ADHD in children ages 6-12 years at all measured times (1, 2, 4, 6, 8, 10, 12, and 13 hours after taking) compared to a sugar syrup.
DYANAVEL XR works within as little as 1 hour and keeps working for 13 hours after taking. That means that if taken at 7 am, DYANAVEL XR can be effective through evening time. In a clinical study performed in a laboratory classroom, DYANAVEL XR was found effective at reducing the symptoms of ADHD in children ages 6-12 years at all measured times (1, 2, 4, 6, 8, 10, 12, and 13 hours after taking) compared to a sugar syrup.
DYANAVEL XR is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep DYANAVEL XR in a safe place to prevent misuse and abuse. Selling or giving away DYANAVEL XR may harm others, and is against the law. Tell your healthcare provider if you or your child have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.
Enter your email address to receive a link to the DYANAVEL® XR (amphetamine) Patient Brochure.
Enter your email address to receive a link to the DYANAVEL® XR (amphetamine) Patient Brochure.
Enter your email address to join the DYANAVEL® XR (amphetamine) community.
Important Safety Information & Approved Use
DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.
DYANAVEL® XR (amphetamine), Quillivant XR® (methylphenidate HCI), and QuilliChew ER® (methylphenidate HCI) are federally controlled substances (CII) because they can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR, Quillivant XR, and QuilliChew ER have a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep these medicines in a safe place to prevent abuse and misuse. Selling or giving away these medicines may harm others and is against the law.
Your healthcare provider should check you or your child’s risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR, Quillivant XR, and QuilliChew ER and will monitor you or your child during treatment. Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol, prescription medicines, or street drugs.
To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Important Safety Information & Approved Use
DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.
– Your healthcare provider should check you or your child's risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR and will monitor you or your child during treatment.
– Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol prescription medicines, or street drugs.
DYANAVEL XR should not be taken if you or your child are allergic to amphetamine or any of the ingredients in DYANAVEL XR or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI including the antibiotic linezolid and the intravenous medicine methylene blue.
DYANAVEL XR can cause serious side effects including:
Risks for people with serious heart disease: Sudden death has happened in people who have heart defects or other serious heart disease. Before starting DYANAVEL XR, tell your healthcare provider if you or your child have any heart problems, heart disease, or heart defects. Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting during treatment with DYANAVEL XR.
Increase in blood pressure and heart rate.
Your healthcare provider should check your or your child’s blood pressure and heart rate regularly during treatment with DYANAVEL XR.
Mental (psychiatric) problems, including new or worse behavior and thought problems, new or worse bipolar illness, new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms.
Tell your healthcare provider about any mental problems you or your child have, or about a family history of suicide, bipolar illness, or depression. Call the doctor right away if there are any new or worsening mental symptoms during treatment.
Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Tell your healthcare provider if you or your child have numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes. Call the doctor right away if you or your child have any signs of unexplained wounds appearing on fingers or toes during treatment with DYANAVEL XR.
New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare provider if you or your child get any new or worsening tics or worsening Tourette’s syndrome during treatment with DYANAVEL XR.
Serotonin Syndrome. This problem may happen when DYANAVEL XR is taken with certain other medicines and may be life-threatening. Stop taking DYANAVEL XR and call your healthcare provider or go to the nearest hospital emergency room if you get symptoms such as agitation, hallucinations, coma, or other changes in mental status; fast heartbeat; sweating or fever; nausea, vomiting, diarrhea; high or low blood pressure; problems controlling movements or muscle twitching; muscle stiffness or tightness.
Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment with DYANAVEL XR. Your healthcare provider may stop your child’s DYANAVEL XR treatment if they are not growing or gaining weight as expected.
It is not known if DYANAVEL XR will harm the unborn baby. There is a pregnancy registry for females who are exposed to DYANAVEL XR during pregnancy. The purpose of the registry is to collect information about the health of females exposed to DYANAVEL XR and their baby. If you or your child becomes pregnant during treatment with DYANAVEL XR, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants at 1-866-961-2388 or visit https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/.
DYANAVEL XR passes into breast milk. You or your child should not breastfeed during treatment with DYANAVEL XR. Tell your doctor if you are breastfeeding or plan to breastfeed.
The most common side effects of amphetamine products include:
– dry mouth
– decreased appetite
– weight loss
– stomach pain
– nausea
– trouble sleeping
– restlessness
– extreme mood changes
– dizziness
– increased heart rate
Talk to your doctor if you or your child have any side effects that bother you or do not go away.
Avoid drinking alcohol while taking DYANAVEL XR.
To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
APPROVED USE
DYANAVEL XR is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. DYANAVEL XR may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.
It is not known if DYANAVEL XR is safe and effective in children under 6 years of age.